A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Conditions
Hypertrophic Cardiomyopathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Local Institution - 0008, Beijing, Beijing Municipality, China
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Zhuang Tian)Peking University First Affiliated Hospital, Beijing, Beijing Municipality, China
Local Institution - 0009, Guangzhou, Guangdong, China
The Second Afilliated Hospital of Hebei Medical University, Jiazhuang, Hebei, China
Local Institution - 0003, Harbin, Heilongjiang, China
Local Institution - 0007, Zhengzhou, Henan, China
Suzhou Municipal Hospital, Suzhou, Jiangsu, China
The Second Hospital of Jilin University, Changchun, Jilin, China
Local Institution - 0005, Dalian, Liaoning, China
Local Institution - 0013, Xi'an, Shan3xi, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Xiaojie Xie)Local Institution - 0010, Jinan, China
Zhongshan Hospital Fudan University, Shanghai, China
Study leads
Bristol Myers Squibb
Study Director
Bristol-Myers Squibb